FDA seeks panel's advice on Ebola vaccine R&D, licensure

The FDA plans to convene its Vaccines and Related Biological Products Advisory Committee on 12 May to provide advice and recommendations about the development and licensure of vaccines against Ebola, which has infected about 24,600 people during the current outbreak, killing over 10,100.